These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1861227)

  • 21. Methotrexate efficacy, but not its intolerance, is associated with the dose and route of administration.
    Fráňová J; Fingerhutová Š; Kobrová K; Srp R; Němcová D; Hoza J; Uher M; Saifridová M; Linková L; Doležalová P
    Pediatr Rheumatol Online J; 2016 Jun; 14(1):36. PubMed ID: 27301536
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral low-dose methotrexate (MTX) to be efficient in refractory rheumatoid arthritis and adult-onset Still's disease.
    Kenouch S; Fessi H; Méry JP; Belmatoug N; Kahn MF
    Am J Kidney Dis; 1989 Jul; 14(1):76-7. PubMed ID: 2741938
    [No Abstract]   [Full Text] [Related]  

  • 23. Hepatotoxicity in patients with juvenile idiopathic arthritis receiving longterm methotrexate therapy.
    Lahdenne P; Rapola J; Ylijoki H; Haapasaari J
    J Rheumatol; 2002 Nov; 29(11):2442-5. PubMed ID: 12415606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of methotrexate in juvenile idiopathic arthritis.
    Ramanan AV; Whitworth P; Baildam EM
    Arch Dis Child; 2003 Mar; 88(3):197-200. PubMed ID: 12598376
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Etanercept: an updated review of its use in rheumatoid arthritis, psoriatic arthritis and juvenile rheumatoid arthritis.
    Culy CR; Keating GM
    Drugs; 2002; 62(17):2493-537. PubMed ID: 12421111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prediction of methotrexate intolerance in juvenile idiopathic arthritis: a prospective, observational cohort study.
    van Dijkhuizen EH; Bulatović Ćalasan M; Pluijm SM; de Rotte MC; Vastert SJ; Kamphuis S; de Jonge R; Wulffraat NM
    Pediatr Rheumatol Online J; 2015; 13():5. PubMed ID: 25745368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methotrexate-induced pseudotumor cerebri in a patient with juvenile idiopathic arthritis.
    Incecik F; Ozcanyuz DG; Yılmaz M
    Acta Neurol Belg; 2019 Mar; 119(1):141-142. PubMed ID: 30083940
    [No Abstract]   [Full Text] [Related]  

  • 28. Liver stiffness correlates with methotrexate cumulative dose in patients with rheumatoid arthritis.
    Arena U; Stasi C; Mannoni A; Benucci M; Maddali-Bongi S; Cammelli D; Assarat A; Marra F; Pinzani M
    Dig Liver Dis; 2012 Feb; 44(2):149-53. PubMed ID: 21930442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methotrexate/naproxen-associated severe hepatitis in a child with juvenile idiopathic arthritis.
    Ting TV; Hashkes PJ
    Clin Exp Rheumatol; 2007; 25(6):928-9. PubMed ID: 18173932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. British isles survey of methotrexate monitoring practice during treatment of juvenile idiopathic arthritis.
    Hawley DP; Camina N; Rangaraj S
    Semin Arthritis Rheum; 2011 Feb; 40(4):358-64.e1-2. PubMed ID: 20822799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between cumulative methotrexate dose, non-invasive scoring system and hepatic fibrosis detected by Fibroscan in rheumatoid arthritis patients receiving methotrexate.
    Lertnawapan R; Chonprasertsuk S; Siramolpiwat S
    Int J Rheum Dis; 2019 Feb; 22(2):214-221. PubMed ID: 30565876
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liver histology in patients receiving low dose pulse methotrexate for the treatment of rheumatoid arthritis.
    Willkens RF; Leonard PA; Clegg DO; Tolman KG; Ward JR; Marks CR; Greene ML; Roth GJ; Jackson CG; Cannon GW
    Ann Rheum Dis; 1990 Aug; 49(8):591-3. PubMed ID: 2396863
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glucocorticoids in juvenile idiopathic arthritis.
    Malattia C; Martini A
    Ann N Y Acad Sci; 2014 May; 1318():65-70. PubMed ID: 24738483
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of patients with juvenile rheumatoid arthritis with combination of leflunomide and methotrexate].
    Gao JS; Wu H; Tian J
    Zhonghua Er Ke Za Zhi; 2003 Jun; 41(6):435-8. PubMed ID: 14748999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low dose methotrexate osteopathy in a patient with polyarticular juvenile idiopathic arthritis.
    Quinn MA; Green MJ; Gough AK
    Ann Rheum Dis; 2003 Nov; 62(11):1123-4; author reply 1124. PubMed ID: 14583584
    [No Abstract]   [Full Text] [Related]  

  • 36. Life-threatening pneumonitis complicating low-dose methotrexate treatment for juvenile idiopathic arthritis in a child.
    Liu YC; Tu YL; Wu RC; Huang JL; Yao TC
    Pediatr Emerg Care; 2014 Jun; 30(6):415-7. PubMed ID: 24892681
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low dose methotrexate osteopathy in a patient with polyarticular juvenile idiopathic arthritis.
    Rudler M; Pouchot J; Paycha F; Gentelle S; Grasland A; Vinceneux P
    Ann Rheum Dis; 2003 Jun; 62(6):588-9. PubMed ID: 12759303
    [No Abstract]   [Full Text] [Related]  

  • 38. Macrophage activation syndrome in systemic juvenile rheumatoid arthritis successfully treated with cyclosporine.
    Ravelli A; De Benedetti F; Viola S; Martini A
    J Pediatr; 1996 Feb; 128(2):275-8. PubMed ID: 8636829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methotrexate hepatotoxicity and the premature reporting of Mark Twain's death: both greatly exaggerated.
    Kaplan MM
    Hepatology; 1990 Oct; 12(4 Pt 1):784-6. PubMed ID: 2210682
    [No Abstract]   [Full Text] [Related]  

  • 40. Predicting remission in juvenile rheumatoid arthritis with methotrexate treatment.
    Wallace CA; Sherry DD; Mellins ED; Aiken RP
    J Rheumatol; 1993 Jan; 20(1):118-22. PubMed ID: 8441141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.